Biochemical parameters of bronchoalveolar lavage fluid in fat embolism
Tóm tắt
To identify diagnostic markers distinguishing between acute lung injury/acute respiratory distress syndrome (ALI/ARDS) due to fat embolism syndrome (FES) and that due to other causes, and to investigate whether phospholipase A2 and platelet-activating factor (PAF) play a role in the pathogenesis of ALI due to FES. A prospective study in a 14-bed ICU. We studied 13 patients with FES, 11 with ALI/ARDS from other causes (6 without trauma, ALI/ARDS group 1; 7 with trauma, ALI/ARDS group 2) and 5 without cardiopulmonary disease. We compared broncholveolar lavage (BAL) fluid alterations in the respective groups. Total BAL protein in FES group was significantly higher compared to in ALI/ARDS group 1 and controls but ALI/ARDS group 2. Higher total phospholipids were found than in other groups. The alterations in individual phospholipid classes were similar to those in ALI/ARDS patients. However, total cholesterol, lipid esters, and monoglycerides were significantly higher in FES than in other groups. The level of PAF in FES was significantly higher and there was an inverse correlation between PAF and PAF-acetylhydrolase. Phospholipase A2 activity was significantly higher in both FES and ALI/ARDS groups than in control. The levels of neutral lipids and especially cholesterol and cholesterol esters in BAL can be used to distinguish patients with FES from ALI/ARDS due to other predisposing factors. Phospholipase A2 may be involved in the development, and PAF-acetylhydrolase in the downregulation of inflammation in FES.
Tài liệu tham khảo
Mimoz O, Edouard A, Beydon L, Quillard J, Verra F, Fleury J, Bonnet F, Samii K (1995) Contribution of bronchoalveolar lavage to the diagnosis of posttraumatic pulmonary fat embolism. Intensive Care Med 21:973–980
Peltier LF (1969) Fat embolism A current concept. Clin Orthop 66:241–253
Chastre J, Fagon JY, Soler P Fichelle A, Dombret MC, Huten D (1990) Bronchoalveolar lavage for rapid diagnosis of the fat embolism syndrome in trauma patients. Ann Intern Med 113:583–588
Jacobovitz-Derks D, Derks CM (1979) Pulmonary neutral fat embolism in dogs. Am J Pathol 95:30–38
Rocco PR, Zin WA (2005) Pulmonary and extrapulmonary acute respiratory distress syndrome: are they different? Curr Opin Crit Care 11:10–17
Gurd AR (1970) Fat embolism: an aid to diagnosis. J Bone Joint Surg Br 52:732–737
Stanley JD, Hanson RR, Hicklin GA, Glazier AJ Jr, Ervanian A, Jadali M (1994) Specificity of bronchoalveolar lavage for the diagnosis of fat embolism syndrome. Am Surg 60:537–541
Vedrinne JM, Guillaume C, Gagnieu MC, Gratadour P, Fleuret C, Motin J (1992) Bronchoalveolar lavage in trauma patients for diagnosis of fat embolism syndrome: Chest 102:1323–1327
Riseborough EJ, Herndon JH (1976) Alterations in pulmonary function coagulation and fat metabolism in patients with fractures of the lower limbs. Clin Orthop 115:248–267
Nakos G, Kitsiouli EI, Hatzidaki E, Koulouras V, Touqui L, Lekka ME (2005) Phospholipases A2 and PAF-acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 33:772–779
Nakos G, Pneumatikos J, Tsangaris H, Tellis K, Lekka ME (1997) Protein and phospholipids in BAL from patients with Hydrostatic pulmonary edema. Am J Respir Crit Care Med 155:945–951
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem 193:466–468
Bartlett GR (1959) Phosphorus assay in column chromatography. J Biol Chem 234:466–468
Nakos G, Kitsiouli E, Tsangaris I, Lekka ME (1998) Bronchoalveolar lavage fluid characteristics of early, intermediate and late phases of ARDS. Intensive Care Med 24:296–303
Nakos G, Kitsiouli E, Lekka ME (1998) Bronchoalveolar lavage alterations in pulmonary embolism. Am J Respir Crit Care Med 155:945–950
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Kitsiouli EI, Nakos G, Lekka ME (1999) Differential determination of phospholipase A2 and PAF-acetylhydrolase in biological fluids using fluorescent substrates. J Lipid Res 40:2346–2356
Courchaine AJ, Miller WH, Stein DBs Jr (1959) Rapid semi-micro procedure for estimating free and total cholesterol. Clin Chem 5:609–614
Morrison WR, Smith LS (1964) Preparation of fatty acid methyl esters and dimethyl acetals from lipids with boron fluoride-methanol. J Lipid Res 5:600–608
Godeau B, Schaeffer A, Bachir D et al (1996) Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: Value for diagnostic assessment of fat embolism. Am J Respir Crit Care Med 153:1691–1696
Vichinsky E, Williams R, Das M et al (1994) Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 83:3107–31012
Kikkawa Y, Smith F (1983) Cellular and biochemical aspects of pulmonary surfactant in health and disease. Lab Invest 49:122–139
Fisher AB (1990) Regulation of lung surfactant secretion. Am J Physiol 258:L241–L251
Wright JR, Dodds LG (1991) Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 53:395–414
Oyarzun MJ, Clements JA (1978) Control of lung surfactant by ventilation, adrenergic mediators and prostaglandins in the rabbit. Am Rev Respir Dis 117:879–891
Frankel RA, Narahara H, Eguchi H, Toyoshima K, Johnston JM (1993) Metabolism of hexadecanol by rat type II pneumonocytes. Biochem Biophys Res Commun 196:885–891
Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM (2002) The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30:S294–S301
Hite RD, Seeds MC, Jacinto RB, Balasubramanian R, Waite M, Bass D (1998) Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipase A2. Am J Physiol 275: L740–L747
Holm BA, Keicher L, Liu MY, Sokolowski J, Enhorning G (1991) Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 71:317–321
Furue S, Kuwabara K, Mikawa K, Nishina K, Shiga M, Maekawa N, Ueno M, Chikazawa Y, Ono T, Hori Y et al (1999) Crucial role of group II Phospholipase A2 in oleicacid induced acute lung injury in rabbits. Am J Respir Crit Care Med 160:1292–1302
Arbibe L, Vial D, Rosinski-Chupin I, Havet N, Huerre M, Vargaftig BB, Touqui L (1997) Endotoxin induces expression of type II phospholipase A2 in macrophages during acute lung injury in guinea pigs: involvement of TNF-alpha in lipopolysacharide-induced type II phospholipase A2 synthesis. J Immunol 159:391–400
Nevalainen TJ, Haapamaki MM, Gronroos JM (2000) Roles of phospholipases A2 in inflammatory diseases and trauma. Biochim Biophys Acta 1488:83–90
Rautanen M, Gullichsen E, Gronroos J, Kuttila K, Nelimarkka O, Niikoski J, Nevalainen TJ (1997) Catalytic activity of phospholipase A2 in serum in experimental fat embolism in pigs. Eur J Surg 163:449–456
Von Wichert P, Joseph K, Muller B, Frank WM (1993) Bronchoalveolar lavage. Quantification of intraalveolar fluid. Am Rev Respir Dis 147:148–152
Pittet JF, Mackersie RC, Martin TR, Matthay MA (1997) Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155:1187–1205
Matthay MA, Berthiaume Y, Staub NC (1985) Long-term clearance of liquid and protein of unanesthetized sheep. J Appl Physiol 59:928–934